AptarGroup, Inc. has announced a significant leadership transition as Stephan Tanda, the current President and Chief Executive Officer, plans to retire effective September 1, 2026. The Board of Directors has appointed Gael Touya, who currently serves as the President of Aptar Pharma, to succeed Tanda as President and CEO. This transition is expected to facilitate a smooth handover of responsibilities and maintain the company's strategic direction. Tanda will continue to serve as a Board member until the end of the year, ensuring continuity during this period of change. The company has also entered into an Employment Agreement with Touya, which includes a base salary of $1,060,000 and a target annual performance incentive set at 120% of his base salary for the remainder of 2026. Additionally, Touya will be eligible for long-term incentive awards and other benefits consistent with his new role. The leadership change is anticipated to positively impact AptarGroup's strategic execution and operational performance, aligning with the company's growth objectives.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.